Publication | Open Access
Serum levels of ACE2 are higher in patients with obesity and diabetes
37
Citations
19
References
2020
Year
ACE2 levels are higher in some patient groups with comorbidities linked to COVID-19 including obesity and T2D and as such may have an emerging role as a circulating biomarker for severity of outcome in the disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1